SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Viral Reservoirs/Antiretroviral Therapy Randomized Clinical Trials
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
Oral Abstract Moderator
Alexandra L Calmy
University Hospital Geneva, University of Geneva, Geneva, Switzerland
Safety, Immunologic and Virologic Activity of Anti-PD-L1 in HIV-1 Participants on ART
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Effect of Sequential Vacc-4x/GM-CSF Immunization and Romidepsin on the HIV Reservoir
Ole Schmeltz Søgaard
Aarhus University Hospital, Aarhus, Denmark
A Patient Navigation/Contingency Management RCT for Hospitalized HIV+ Substance Users
Lisa R. Metsch
Columbia University Mailman School of Public Health, New York, NY, United States
Initiating ART at a Patient's First Clinic Visit: The RapIT Randomized Trial
Sydney Rosen
Boston University, Boston, MA, United States
Switching Tenofovir DF to Tenofovir Alafenamide in Virologically Suppressed Adults
Joel Gallant
Southwest Care Center, Santa Fe, NM, United States
ACTG 5273 Randomized Trial of Second-Line ART Supports WHO Guidance
Alberto M. La Rosa
Asociación Civil Impacta Salud y Educación, Lima, Peru
Cabotegravir+Rilpivirine as Long-Acting Maintenance Therapy: LATTE-2 Week 32 Results
David A. Margolis
ViiV Healthcare, Research Triangle Park, NC, United States
ACTG 5340:The Effect of VRC01 on Viral Kinetics After Analytic Treatment Interruption
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
